Active Pharmaceutical Ingredients
Itraconazole Pellets are multiparticulate systems designed for enhanced absorption and consistent therapeutic effect in antifungal treatments. Formulated using layered or coated techniques, these pellets ensure improved bioavailability of Itraconazole, which is known for its poor solubility. Ideal for oral capsule and sachet formulations, they offer flexibility in dosing and can be customized for immediate or sustained release profiles.
| Component | Function |
|---|---|
| Itraconazole | Active Pharmaceutical Ingredient (API) |
| Sugar / MCC Pellets | Inert core / Neutral starter spheres |
| HPMC / PVP | Binder / Layering polymer |
| Eudragit RS / S100 | Controlled or enteric coating polymer |
| PEG 6000 / Triethyl Citrate | Plasticizer for flexible coating |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Purified Water | Solvent (evaporated during processing) |
Sourcing Itraconazole Pellets from Salius Pharma gives you access to high-quality, customizable antifungal pellets manufactured in USFDA-approved and WHO-GMP-certified facilities in India. We support flexible pellet strengths, regulatory documentation (CTD, CoA, MSDS), and efficient logistics across Africa, Southeast Asia, CIS, and LATAM. Our deep expertise in pelletization and supply chain management ensures consistent quality, timely delivery, and full regulatory support to accelerate your market readiness.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Itraconazole Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Pelletization allows uniform drug distribution, customizable release profiles, and better dissolution of poorly soluble Itraconazole, enhancing absorption and therapeutic efficacy in oral dosage forms.
Yes. The pellets are versatile and compatible with hard gelatin capsules, sachets, and multiparticulate oral suspensions, providing flexibility for different formulation needs.
Salius Pharma offers custom drug loads, tailored coating materials (HPMC, Eudragit), and release profiles (IR, SR, delayed release) to meet specific market or regulatory requirements.
All batches undergo stringent quality control, stability testing, and GMP-compliant manufacturing, and are shipped in export-grade packaging with complete documentation (CoA, MSDS, stability reports) to ensure safe delivery worldwide.